nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—XDH—Cisplatin—germ cell cancer	0.177	0.305	CbGbCtD
L-Carnitine—MPO—Cisplatin—germ cell cancer	0.177	0.305	CbGbCtD
L-Carnitine—SLC22A5—Dactinomycin—germ cell cancer	0.138	0.238	CbGbCtD
L-Carnitine—SLCO1B1—Methotrexate—germ cell cancer	0.0456	0.0788	CbGbCtD
L-Carnitine—SLC22A8—Methotrexate—germ cell cancer	0.0421	0.0727	CbGbCtD
L-Carnitine—SLC22A16—Organic cation transport—SLC22A3—germ cell cancer	0.0225	0.149	CbGpPWpGaD
L-Carnitine—SLC25A20—Import of palmitoyl-CoA into the mitochondrial matrix—CRABP1—germ cell cancer	0.0153	0.101	CbGpPWpGaD
L-Carnitine—SLC22A16—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.0153	0.101	CbGpPWpGaD
L-Carnitine—CPT2—Import of palmitoyl-CoA into the mitochondrial matrix—CRABP1—germ cell cancer	0.00983	0.0651	CbGpPWpGaD
L-Carnitine—SLC22A4—Organic cation transport—SLC22A3—germ cell cancer	0.00832	0.0551	CbGpPWpGaD
L-Carnitine—SLC22A8—choroid plexus—germ cell cancer	0.0081	0.0438	CbGeAlD
L-Carnitine—CROT—Vinorelbine—Vinblastine—germ cell cancer	0.00729	1	CbGdCrCtD
L-Carnitine—CPT1A—Import of palmitoyl-CoA into the mitochondrial matrix—CRABP1—germ cell cancer	0.00681	0.0451	CbGpPWpGaD
L-Carnitine—SLC22A5—Organic cation transport—SLC22A3—germ cell cancer	0.00626	0.0415	CbGpPWpGaD
L-Carnitine—SLC25A29—ganglion—germ cell cancer	0.00626	0.0338	CbGeAlD
L-Carnitine—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00564	0.0374	CbGpPWpGaD
L-Carnitine—Choline—SLC22A3—germ cell cancer	0.00471	1	CrCbGaD
L-Carnitine—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00424	0.0281	CbGpPWpGaD
L-Carnitine—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00384	0.0254	CbGpPWpGaD
L-Carnitine—SLC25A29—neck—germ cell cancer	0.00356	0.0192	CbGeAlD
L-Carnitine—SLC22A8—optic choroid—germ cell cancer	0.00311	0.0168	CbGeAlD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.0031	0.0205	CbGpPWpGaD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00306	0.0202	CbGpPWpGaD
L-Carnitine—SLC22A16—gonad—germ cell cancer	0.00256	0.0138	CbGeAlD
L-Carnitine—SLC25A20—trigeminal ganglion—germ cell cancer	0.00245	0.0132	CbGeAlD
L-Carnitine—SLC25A29—telencephalon—germ cell cancer	0.00241	0.013	CbGeAlD
L-Carnitine—CRAT—trigeminal ganglion—germ cell cancer	0.00238	0.0129	CbGeAlD
L-Carnitine—CROT—telencephalon—germ cell cancer	0.00221	0.012	CbGeAlD
L-Carnitine—SLC22A8—urine—germ cell cancer	0.00217	0.0117	CbGeAlD
L-Carnitine—SLC22A16—bone marrow—germ cell cancer	0.00215	0.0116	CbGeAlD
L-Carnitine—CROT—skin of body—germ cell cancer	0.00211	0.0114	CbGeAlD
L-Carnitine—CROT—decidua—germ cell cancer	0.0021	0.0113	CbGeAlD
L-Carnitine—SLC25A29—pituitary gland—germ cell cancer	0.00197	0.0106	CbGeAlD
L-Carnitine—SLC22A16—endocrine gland—germ cell cancer	0.00193	0.0104	CbGeAlD
L-Carnitine—SLC25A29—medulla oblongata—germ cell cancer	0.0019	0.0102	CbGeAlD
L-Carnitine—CRAT—telencephalon—germ cell cancer	0.00187	0.0101	CbGeAlD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.00186	0.0123	CbGpPWpGaD
L-Carnitine—SLC22A16—testis—germ cell cancer	0.00184	0.00995	CbGeAlD
L-Carnitine—SLC25A20—skin of body—germ cell cancer	0.00184	0.00993	CbGeAlD
L-Carnitine—CROT—uterus—germ cell cancer	0.00184	0.00992	CbGeAlD
L-Carnitine—CPT2—trigeminal ganglion—germ cell cancer	0.00183	0.00989	CbGeAlD
L-Carnitine—SLC25A20—decidua—germ cell cancer	0.00183	0.00986	CbGeAlD
L-Carnitine—CROT—pituitary gland—germ cell cancer	0.0018	0.00974	CbGeAlD
L-Carnitine—CRAT—skin of body—germ cell cancer	0.00178	0.00963	CbGeAlD
L-Carnitine—CRAT—decidua—germ cell cancer	0.00177	0.00957	CbGeAlD
L-Carnitine—SLC25A29—adrenal gland—germ cell cancer	0.00176	0.00948	CbGeAlD
L-Carnitine—SLC25A29—midbrain—germ cell cancer	0.00173	0.00936	CbGeAlD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.0017	0.0113	CbGpPWpGaD
L-Carnitine—SLC25A29—spinal cord—germ cell cancer	0.00169	0.00914	CbGeAlD
L-Carnitine—CPT1A—eye—germ cell cancer	0.00166	0.00897	CbGeAlD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00164	0.0109	CbGpPWpGaD
L-Carnitine—SLC25A29—female gonad—germ cell cancer	0.00164	0.00884	CbGeAlD
L-Carnitine—CROT—adrenal gland—germ cell cancer	0.00161	0.0087	CbGeAlD
L-Carnitine—SLC25A20—uterus—germ cell cancer	0.0016	0.00863	CbGeAlD
L-Carnitine—MPO—endothelium—germ cell cancer	0.00159	0.00861	CbGeAlD
L-Carnitine—CROT—midbrain—germ cell cancer	0.00159	0.00859	CbGeAlD
L-Carnitine—CPT2—eye—germ cell cancer	0.00158	0.00852	CbGeAlD
L-Carnitine—SLC25A20—pituitary gland—germ cell cancer	0.00157	0.00847	CbGeAlD
L-Carnitine—CPT2—retina—germ cell cancer	0.00156	0.00844	CbGeAlD
L-Carnitine—CRAT—gonad—germ cell cancer	0.00156	0.00842	CbGeAlD
L-Carnitine—SLCO1B1—Transport of organic anions—AVP—germ cell cancer	0.00156	0.0103	CbGpPWpGaD
L-Carnitine—CROT—bone marrow—germ cell cancer	0.00156	0.00841	CbGeAlD
L-Carnitine—CRAT—uterus—germ cell cancer	0.00155	0.00837	CbGeAlD
L-Carnitine—Fluid overload—Cisplatin—germ cell cancer	0.00154	0.0212	CcSEcCtD
L-Carnitine—SLC25A29—endocrine gland—germ cell cancer	0.00152	0.00822	CbGeAlD
L-Carnitine—CRAT—pituitary gland—germ cell cancer	0.00152	0.00822	CbGeAlD
L-Carnitine—CPT1A—telencephalon—germ cell cancer	0.00151	0.00818	CbGeAlD
L-Carnitine—SLC25A20—medulla oblongata—germ cell cancer	0.00151	0.00817	CbGeAlD
L-Carnitine—SLC25A29—head—germ cell cancer	0.0015	0.00812	CbGeAlD
L-Carnitine—CROT—female gonad—germ cell cancer	0.0015	0.00811	CbGeAlD
L-Carnitine—MPO—blood vessel—germ cell cancer	0.00147	0.00794	CbGeAlD
L-Carnitine—CRAT—medulla oblongata—germ cell cancer	0.00147	0.00793	CbGeAlD
L-Carnitine—SLC25A29—testis—germ cell cancer	0.00145	0.00784	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00141	0.00934	CbGpPWpGaD
L-Carnitine—SLC25A20—adrenal gland—germ cell cancer	0.0014	0.00757	CbGeAlD
L-Carnitine—CROT—endocrine gland—germ cell cancer	0.0014	0.00754	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00139	0.0092	CbGpPWpGaD
L-Carnitine—SLC25A20—midbrain—germ cell cancer	0.00138	0.00747	CbGeAlD
L-Carnitine—CROT—head—germ cell cancer	0.00138	0.00745	CbGeAlD
L-Carnitine—CPT2—skin of body—germ cell cancer	0.00137	0.00741	CbGeAlD
L-Carnitine—CPT2—decidua—germ cell cancer	0.00136	0.00736	CbGeAlD
L-Carnitine—CRAT—adrenal gland—germ cell cancer	0.00136	0.00734	CbGeAlD
L-Carnitine—SLC25A20—bone marrow—germ cell cancer	0.00135	0.00732	CbGeAlD
L-Carnitine—SLC25A20—spinal cord—germ cell cancer	0.00135	0.00729	CbGeAlD
L-Carnitine—CRAT—midbrain—germ cell cancer	0.00134	0.00725	CbGeAlD
L-Carnitine—SLC25A29—cerebellum—germ cell cancer	0.00134	0.00724	CbGeAlD
L-Carnitine—CROT—testis—germ cell cancer	0.00133	0.00719	CbGeAlD
L-Carnitine—CRAT—bone marrow—germ cell cancer	0.00131	0.0071	CbGeAlD
L-Carnitine—CRAT—spinal cord—germ cell cancer	0.00131	0.00707	CbGeAlD
L-Carnitine—SLC25A20—female gonad—germ cell cancer	0.00131	0.00706	CbGeAlD
L-Carnitine—CRAT—female gonad—germ cell cancer	0.00127	0.00685	CbGeAlD
L-Carnitine—CPT1A—gonad—germ cell cancer	0.00126	0.00683	CbGeAlD
L-Carnitine—CES1—neck—germ cell cancer	0.00126	0.0068	CbGeAlD
L-Carnitine—CPT2—PPAR Alpha Pathway—MYC—germ cell cancer	0.00125	0.00825	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian Clock—AVP—germ cell cancer	0.00123	0.00818	CbGpPWpGaD
L-Carnitine—CROT—cerebellum—germ cell cancer	0.00123	0.00664	CbGeAlD
L-Carnitine—SLC25A20—endocrine gland—germ cell cancer	0.00121	0.00656	CbGeAlD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.0012	0.00795	CbGpPWpGaD
L-Carnitine—CPT2—gonad—germ cell cancer	0.0012	0.00648	CbGeAlD
L-Carnitine—SLC25A20—head—germ cell cancer	0.0012	0.00648	CbGeAlD
L-Carnitine—CPT2—uterus—germ cell cancer	0.00119	0.00644	CbGeAlD
L-Carnitine—CRAT—endocrine gland—germ cell cancer	0.00118	0.00637	CbGeAlD
L-Carnitine—CPT2—pituitary gland—germ cell cancer	0.00117	0.00632	CbGeAlD
L-Carnitine—CRAT—head—germ cell cancer	0.00116	0.00629	CbGeAlD
L-Carnitine—SLC25A20—testis—germ cell cancer	0.00116	0.00626	CbGeAlD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00115	0.00761	CbGpPWpGaD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00113	0.00749	CbGpPWpGaD
L-Carnitine—CPT2—medulla oblongata—germ cell cancer	0.00113	0.0061	CbGeAlD
L-Carnitine—CRAT—testis—germ cell cancer	0.00112	0.00607	CbGeAlD
L-Carnitine—CPT1A—adrenal gland—germ cell cancer	0.0011	0.00595	CbGeAlD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00109	0.00725	CbGpPWpGaD
L-Carnitine—SLC25A29—brain—germ cell cancer	0.00109	0.00588	CbGeAlD
L-Carnitine—SLC25A20—cerebellum—germ cell cancer	0.00107	0.00578	CbGeAlD
L-Carnitine—SLC25A29—lymph node—germ cell cancer	0.00105	0.00569	CbGeAlD
L-Carnitine—CPT2—adrenal gland—germ cell cancer	0.00105	0.00565	CbGeAlD
L-Carnitine—CRAT—cerebellum—germ cell cancer	0.00104	0.00561	CbGeAlD
L-Carnitine—CPT2—midbrain—germ cell cancer	0.00103	0.00558	CbGeAlD
L-Carnitine—CPT1A—female gonad—germ cell cancer	0.00103	0.00555	CbGeAlD
L-Carnitine—Injury—Bleomycin—germ cell cancer	0.00102	0.0142	CcSEcCtD
L-Carnitine—CPT2—bone marrow—germ cell cancer	0.00101	0.00546	CbGeAlD
L-Carnitine—CPT2—spinal cord—germ cell cancer	0.00101	0.00544	CbGeAlD
L-Carnitine—CES1—NRF2 pathway—SLC2A3—germ cell cancer	0.000999	0.00662	CbGpPWpGaD
L-Carnitine—CROT—brain—germ cell cancer	0.000999	0.0054	CbGeAlD
L-Carnitine—Cardiovascular disorder—Etoposide—germ cell cancer	0.000996	0.0138	CcSEcCtD
L-Carnitine—CPT2—female gonad—germ cell cancer	0.000975	0.00527	CbGeAlD
L-Carnitine—CROT—lymph node—germ cell cancer	0.000965	0.00521	CbGeAlD
L-Carnitine—SLC22A4—neck—germ cell cancer	0.00096	0.00518	CbGeAlD
L-Carnitine—CPT1A—endocrine gland—germ cell cancer	0.000955	0.00516	CbGeAlD
L-Carnitine—CPT1A—head—germ cell cancer	0.000943	0.00509	CbGeAlD
L-Carnitine—Hyperkalaemia—Cisplatin—germ cell cancer	0.000939	0.013	CcSEcCtD
L-Carnitine—CPT1A—testis—germ cell cancer	0.000911	0.00492	CbGeAlD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000909	0.00602	CbGpPWpGaD
L-Carnitine—CPT2—endocrine gland—germ cell cancer	0.000906	0.0049	CbGeAlD
L-Carnitine—CPT2—head—germ cell cancer	0.000895	0.00483	CbGeAlD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000873	0.00578	CbGpPWpGaD
L-Carnitine—SLC25A20—brain—germ cell cancer	0.000869	0.00469	CbGeAlD
L-Carnitine—CPT2—testis—germ cell cancer	0.000864	0.00467	CbGeAlD
L-Carnitine—CPT1A—PPAR Alpha Pathway—MYC—germ cell cancer	0.000863	0.00572	CbGpPWpGaD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000863	0.00572	CbGpPWpGaD
L-Carnitine—Depression—Vinblastine—germ cell cancer	0.000857	0.0118	CcSEcCtD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00085	0.00563	CbGpPWpGaD
L-Carnitine—Atrial fibrillation—Ifosfamide—germ cell cancer	0.000849	0.0117	CcSEcCtD
L-Carnitine—CRAT—brain—germ cell cancer	0.000843	0.00455	CbGeAlD
L-Carnitine—CPT1A—cerebellum—germ cell cancer	0.000841	0.00454	CbGeAlD
L-Carnitine—SLC25A20—lymph node—germ cell cancer	0.00084	0.00454	CbGeAlD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000832	0.00551	CbGpPWpGaD
L-Carnitine—CRAT—lymph node—germ cell cancer	0.000815	0.0044	CbGeAlD
L-Carnitine—CPT2—cerebellum—germ cell cancer	0.000798	0.00431	CbGeAlD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00078	0.00517	CbGpPWpGaD
L-Carnitine—Haemoglobin—Vinblastine—germ cell cancer	0.000775	0.0107	CcSEcCtD
L-Carnitine—Haemorrhage—Vinblastine—germ cell cancer	0.000771	0.0107	CcSEcCtD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000769	0.00509	CbGpPWpGaD
L-Carnitine—Pharyngitis—Vinblastine—germ cell cancer	0.000765	0.0106	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000742	0.00492	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000742	0.00492	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—H2AFZ—germ cell cancer	0.000741	0.00491	CbGpPWpGaD
L-Carnitine—Weight decreased—Bleomycin—germ cell cancer	0.000736	0.0102	CcSEcCtD
L-Carnitine—SLC22A8—trigeminal ganglion—germ cell cancer	0.000725	0.00392	CbGeAlD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000716	0.00475	CbGpPWpGaD
L-Carnitine—XDH—endocrine gland—germ cell cancer	0.000706	0.00381	CbGeAlD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000705	0.00467	CbGpPWpGaD
L-Carnitine—CPT1A—brain—germ cell cancer	0.000683	0.00369	CbGeAlD
L-Carnitine—MPO—C-MYB transcription factor network—KITLG—germ cell cancer	0.000682	0.00452	CbGpPWpGaD
L-Carnitine—MPO—skin of body—germ cell cancer	0.00068	0.00367	CbGeAlD
L-Carnitine—CPT1A—lymph node—germ cell cancer	0.00066	0.00357	CbGeAlD
L-Carnitine—Haemoglobin—Bleomycin—germ cell cancer	0.000655	0.00904	CcSEcCtD
L-Carnitine—Haemorrhage—Bleomycin—germ cell cancer	0.000651	0.009	CcSEcCtD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.00065	0.00431	CbGpPWpGaD
L-Carnitine—CPT2—brain—germ cell cancer	0.000648	0.0035	CbGeAlD
L-Carnitine—CPT2—lymph node—germ cell cancer	0.000627	0.00339	CbGeAlD
L-Carnitine—SLC22A8—eye—germ cell cancer	0.000625	0.00338	CbGeAlD
L-Carnitine—CES1—adrenal gland—germ cell cancer	0.000621	0.00335	CbGeAlD
L-Carnitine—Anaemia—Vinblastine—germ cell cancer	0.00062	0.00857	CcSEcCtD
L-Carnitine—SLC22A4—decidua—germ cell cancer	0.000617	0.00333	CbGeAlD
L-Carnitine—Renal failure—Ifosfamide—germ cell cancer	0.000609	0.00842	CcSEcCtD
L-Carnitine—Vertigo—Vinblastine—germ cell cancer	0.000603	0.00833	CcSEcCtD
L-Carnitine—Pharyngitis—Dactinomycin—germ cell cancer	0.000603	0.00833	CcSEcCtD
L-Carnitine—Convulsion—Vinblastine—germ cell cancer	0.000582	0.00804	CcSEcCtD
L-Carnitine—MPO—pituitary gland—germ cell cancer	0.00058	0.00314	CbGeAlD
L-Carnitine—Hypertension—Vinblastine—germ cell cancer	0.00058	0.00801	CcSEcCtD
L-Carnitine—CES1—female gonad—germ cell cancer	0.000579	0.00313	CbGeAlD
L-Carnitine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000578	0.00383	CbGpPWpGaD
L-Carnitine—Haemoglobin—Ifosfamide—germ cell cancer	0.000559	0.00773	CcSEcCtD
L-Carnitine—Haemorrhage—Ifosfamide—germ cell cancer	0.000557	0.00769	CcSEcCtD
L-Carnitine—SLC22A5—trigeminal ganglion—germ cell cancer	0.000548	0.00296	CbGeAlD
L-Carnitine—CES1—endocrine gland—germ cell cancer	0.000538	0.00291	CbGeAlD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000536	0.00355	CbGpPWpGaD
L-Carnitine—CES1—head—germ cell cancer	0.000531	0.00287	CbGeAlD
L-Carnitine—SLC22A4—pituitary gland—germ cell cancer	0.00053	0.00286	CbGeAlD
L-Carnitine—Renal failure—Cisplatin—germ cell cancer	0.000525	0.00726	CcSEcCtD
L-Carnitine—Anaemia—Bleomycin—germ cell cancer	0.000524	0.00724	CcSEcCtD
L-Carnitine—Anorexia—Vinblastine—germ cell cancer	0.000522	0.00722	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000522	0.00346	CbGpPWpGaD
L-Carnitine—Eye disorder—Ifosfamide—germ cell cancer	0.00052	0.00719	CcSEcCtD
L-Carnitine—MPO—adrenal gland—germ cell cancer	0.000518	0.0028	CbGeAlD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000514	0.0034	CbGpPWpGaD
L-Carnitine—CES1—testis—germ cell cancer	0.000513	0.00277	CbGeAlD
L-Carnitine—Melaena—Methotrexate—germ cell cancer	0.000512	0.00708	CcSEcCtD
L-Carnitine—Angiopathy—Ifosfamide—germ cell cancer	0.000505	0.00698	CcSEcCtD
L-Carnitine—MPO—bone marrow—germ cell cancer	0.000501	0.00271	CbGeAlD
L-Carnitine—MPO—spinal cord—germ cell cancer	0.000499	0.0027	CbGeAlD
L-Carnitine—Arrhythmia—Ifosfamide—germ cell cancer	0.000497	0.00687	CcSEcCtD
L-Carnitine—Cough—Bleomycin—germ cell cancer	0.000495	0.00684	CcSEcCtD
L-Carnitine—Paraesthesia—Vinblastine—germ cell cancer	0.000492	0.0068	CcSEcCtD
L-Carnitine—Anaemia—Dactinomycin—germ cell cancer	0.000489	0.00675	CcSEcCtD
L-Carnitine—CROT—Metabolism—SLC2A3—germ cell cancer	0.000484	0.00321	CbGpPWpGaD
L-Carnitine—Myalgia—Bleomycin—germ cell cancer	0.000483	0.00667	CcSEcCtD
L-Carnitine—Chest pain—Bleomycin—germ cell cancer	0.000483	0.00667	CcSEcCtD
L-Carnitine—Renal failure—Etoposide—germ cell cancer	0.000481	0.00665	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000478	0.00317	CbGpPWpGaD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000478	0.00316	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—SLC22A3—germ cell cancer	0.000477	0.00316	CbGpPWpGaD
L-Carnitine—Decreased appetite—Vinblastine—germ cell cancer	0.000476	0.00658	CcSEcCtD
L-Carnitine—SLC22A4—adrenal gland—germ cell cancer	0.000473	0.00256	CbGeAlD
L-Carnitine—Pain—Vinblastine—germ cell cancer	0.000468	0.00647	CcSEcCtD
L-Carnitine—Constipation—Vinblastine—germ cell cancer	0.000468	0.00647	CcSEcCtD
L-Carnitine—SLC22A5—retina—germ cell cancer	0.000468	0.00253	CbGeAlD
L-Carnitine—MPO—C-MYB transcription factor network—KIT—germ cell cancer	0.000465	0.00308	CbGpPWpGaD
L-Carnitine—SLCO1B1—endocrine gland—germ cell cancer	0.000462	0.0025	CbGeAlD
L-Carnitine—Infection—Bleomycin—germ cell cancer	0.00046	0.00635	CcSEcCtD
L-Carnitine—SLC22A4—bone marrow—germ cell cancer	0.000458	0.00247	CbGeAlD
L-Carnitine—SLC22A4—spinal cord—germ cell cancer	0.000456	0.00246	CbGeAlD
L-Carnitine—Myalgia—Dactinomycin—germ cell cancer	0.00045	0.00622	CcSEcCtD
L-Carnitine—MPO—endocrine gland—germ cell cancer	0.00045	0.00243	CbGeAlD
L-Carnitine—Eye disorder—Cisplatin—germ cell cancer	0.000448	0.0062	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000448	0.00619	CcSEcCtD
L-Carnitine—Anaemia—Ifosfamide—germ cell cancer	0.000448	0.00619	CcSEcCtD
L-Carnitine—MPO—head—germ cell cancer	0.000444	0.0024	CbGeAlD
L-Carnitine—Anorexia—Bleomycin—germ cell cancer	0.000441	0.00609	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—AVP—germ cell cancer	0.000438	0.0029	CbGpPWpGaD
L-Carnitine—Vertigo—Ifosfamide—germ cell cancer	0.000435	0.00602	CcSEcCtD
L-Carnitine—Abdominal pain—Vinblastine—germ cell cancer	0.000433	0.00598	CcSEcCtD
L-Carnitine—Hypotension—Bleomycin—germ cell cancer	0.000432	0.00597	CcSEcCtD
L-Carnitine—Infection—Dactinomycin—germ cell cancer	0.000429	0.00592	CcSEcCtD
L-Carnitine—MPO—testis—germ cell cancer	0.000429	0.00232	CbGeAlD
L-Carnitine—Arrhythmia—Cisplatin—germ cell cancer	0.000429	0.00592	CcSEcCtD
L-Carnitine—Palpitations—Ifosfamide—germ cell cancer	0.000428	0.00592	CcSEcCtD
L-Carnitine—Cough—Ifosfamide—germ cell cancer	0.000423	0.00584	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000422	0.00583	CcSEcCtD
L-Carnitine—Convulsion—Ifosfamide—germ cell cancer	0.00042	0.0058	CcSEcCtD
L-Carnitine—Hypertension—Ifosfamide—germ cell cancer	0.000418	0.00578	CcSEcCtD
L-Carnitine—Paraesthesia—Bleomycin—germ cell cancer	0.000415	0.00574	CcSEcCtD
L-Carnitine—Dyspnoea—Bleomycin—germ cell cancer	0.000413	0.0057	CcSEcCtD
L-Carnitine—Myalgia—Ifosfamide—germ cell cancer	0.000413	0.0057	CcSEcCtD
L-Carnitine—Chest pain—Ifosfamide—germ cell cancer	0.000413	0.0057	CcSEcCtD
L-Carnitine—CRAT—Metabolism—SLC2A3—germ cell cancer	0.000412	0.00273	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—SLC2A3—germ cell cancer	0.000412	0.00273	CbGpPWpGaD
L-Carnitine—Anorexia—Dactinomycin—germ cell cancer	0.000411	0.00568	CcSEcCtD
L-Carnitine—SLC22A5—skin of body—germ cell cancer	0.000411	0.00222	CbGeAlD
L-Carnitine—Eye disorder—Etoposide—germ cell cancer	0.000411	0.00568	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—SLC22A3—germ cell cancer	0.000405	0.00269	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SLC22A3—germ cell cancer	0.000405	0.00269	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000405	0.00268	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Vinblastine—germ cell cancer	0.000404	0.00558	CcSEcCtD
L-Carnitine—Decreased appetite—Bleomycin—germ cell cancer	0.000402	0.00556	CcSEcCtD
L-Carnitine—Muscle spasms—Cisplatin—germ cell cancer	0.000402	0.00555	CcSEcCtD
L-Carnitine—Angiopathy—Etoposide—germ cell cancer	0.000399	0.00551	CcSEcCtD
L-Carnitine—Pain—Bleomycin—germ cell cancer	0.000396	0.00547	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000393	0.00543	CcSEcCtD
L-Carnitine—Asthenia—Vinblastine—germ cell cancer	0.000393	0.00543	CcSEcCtD
L-Carnitine—Infection—Ifosfamide—germ cell cancer	0.000393	0.00543	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000392	0.0026	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CRABP1—germ cell cancer	0.000389	0.00257	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000386	0.00256	CbGpPWpGaD
L-Carnitine—Anaemia—Cisplatin—germ cell cancer	0.000386	0.00533	CcSEcCtD
L-Carnitine—CES1—brain—germ cell cancer	0.000385	0.00208	CbGeAlD
L-Carnitine—Anorexia—Ifosfamide—germ cell cancer	0.000377	0.00521	CcSEcCtD
L-Carnitine—Decreased appetite—Dactinomycin—germ cell cancer	0.000375	0.00518	CcSEcCtD
L-Carnitine—Diarrhoea—Vinblastine—germ cell cancer	0.000375	0.00518	CcSEcCtD
L-Carnitine—Dysgeusia—Etoposide—germ cell cancer	0.000375	0.00518	CcSEcCtD
L-Carnitine—CES1—lymph node—germ cell cancer	0.000372	0.00201	CbGeAlD
L-Carnitine—Back pain—Etoposide—germ cell cancer	0.00037	0.00511	CcSEcCtD
L-Carnitine—Hypotension—Ifosfamide—germ cell cancer	0.00037	0.00511	CcSEcCtD
L-Carnitine—Pain—Dactinomycin—germ cell cancer	0.000369	0.0051	CcSEcCtD
L-Carnitine—Muscle spasms—Etoposide—germ cell cancer	0.000368	0.00508	CcSEcCtD
L-Carnitine—Body temperature increased—Bleomycin—germ cell cancer	0.000366	0.00505	CcSEcCtD
L-Carnitine—Dizziness—Vinblastine—germ cell cancer	0.000362	0.00501	CcSEcCtD
L-Carnitine—Convulsion—Cisplatin—germ cell cancer	0.000362	0.005	CcSEcCtD
L-Carnitine—SLC22A4—cerebellum—germ cell cancer	0.000362	0.00195	CbGeAlD
L-Carnitine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00036	0.00498	CcSEcCtD
L-Carnitine—Myalgia—Cisplatin—germ cell cancer	0.000356	0.00491	CcSEcCtD
L-Carnitine—Paraesthesia—Ifosfamide—germ cell cancer	0.000355	0.00491	CcSEcCtD
L-Carnitine—SLC22A8—head—germ cell cancer	0.000355	0.00192	CbGeAlD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000355	0.00235	CbGpPWpGaD
L-Carnitine—Anxiety—Cisplatin—germ cell cancer	0.000354	0.0049	CcSEcCtD
L-Carnitine—Anaemia—Etoposide—germ cell cancer	0.000354	0.00489	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000353	0.00488	CcSEcCtD
L-Carnitine—Dyspnoea—Ifosfamide—germ cell cancer	0.000353	0.00487	CcSEcCtD
L-Carnitine—SLC22A5—pituitary gland—germ cell cancer	0.000351	0.00189	CbGeAlD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000349	0.00231	CbGpPWpGaD
L-Carnitine—Vomiting—Vinblastine—germ cell cancer	0.000348	0.00481	CcSEcCtD
L-Carnitine—Vertigo—Etoposide—germ cell cancer	0.000344	0.00475	CcSEcCtD
L-Carnitine—Decreased appetite—Ifosfamide—germ cell cancer	0.000344	0.00475	CcSEcCtD
L-Carnitine—Headache—Vinblastine—germ cell cancer	0.000343	0.00474	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000341	0.00472	CcSEcCtD
L-Carnitine—Abdominal pain—Dactinomycin—germ cell cancer	0.000341	0.00471	CcSEcCtD
L-Carnitine—Body temperature increased—Dactinomycin—germ cell cancer	0.000341	0.00471	CcSEcCtD
L-Carnitine—Hypersensitivity—Bleomycin—germ cell cancer	0.000341	0.00471	CcSEcCtD
L-Carnitine—Infection—Cisplatin—germ cell cancer	0.000339	0.00468	CcSEcCtD
L-Carnitine—SLC22A5—medulla oblongata—germ cell cancer	0.000338	0.00183	CbGeAlD
L-Carnitine—Pain—Ifosfamide—germ cell cancer	0.000338	0.00467	CcSEcCtD
L-Carnitine—Constipation—Ifosfamide—germ cell cancer	0.000338	0.00467	CcSEcCtD
L-Carnitine—Cough—Etoposide—germ cell cancer	0.000334	0.00461	CcSEcCtD
L-Carnitine—Tachycardia—Cisplatin—germ cell cancer	0.000333	0.0046	CcSEcCtD
L-Carnitine—Asthenia—Bleomycin—germ cell cancer	0.000332	0.00459	CcSEcCtD
L-Carnitine—Convulsion—Etoposide—germ cell cancer	0.000332	0.00458	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000331	0.0022	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CRABP1—germ cell cancer	0.00033	0.00219	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CRABP1—germ cell cancer	0.00033	0.00219	CbGpPWpGaD
L-Carnitine—Hypertension—Etoposide—germ cell cancer	0.00033	0.00457	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—AVP—germ cell cancer	0.00033	0.00219	CbGpPWpGaD
L-Carnitine—Pruritus—Bleomycin—germ cell cancer	0.000327	0.00452	CcSEcCtD
L-Carnitine—Chest pain—Etoposide—germ cell cancer	0.000326	0.0045	CcSEcCtD
L-Carnitine—Nausea—Vinblastine—germ cell cancer	0.000325	0.0045	CcSEcCtD
L-Carnitine—Anorexia—Cisplatin—germ cell cancer	0.000325	0.00449	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—TP53—germ cell cancer	0.000325	0.00215	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000323	0.00447	CcSEcCtD
L-Carnitine—MPO—brain—germ cell cancer	0.000322	0.00174	CbGeAlD
L-Carnitine—Hypotension—Cisplatin—germ cell cancer	0.000319	0.0044	CcSEcCtD
L-Carnitine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000318	0.00439	CcSEcCtD
L-Carnitine—SLC22A5—adrenal gland—germ cell cancer	0.000313	0.00169	CbGeAlD
L-Carnitine—Body temperature increased—Ifosfamide—germ cell cancer	0.000313	0.00432	CcSEcCtD
L-Carnitine—Abdominal pain—Ifosfamide—germ cell cancer	0.000313	0.00432	CcSEcCtD
L-Carnitine—MPO—lymph node—germ cell cancer	0.000311	0.00168	CbGeAlD
L-Carnitine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000311	0.00429	CcSEcCtD
L-Carnitine—Infection—Etoposide—germ cell cancer	0.00031	0.00429	CcSEcCtD
L-Carnitine—Asthenia—Dactinomycin—germ cell cancer	0.00031	0.00428	CcSEcCtD
L-Carnitine—SLC22A5—midbrain—germ cell cancer	0.000309	0.00167	CbGeAlD
L-Carnitine—CES1—E2F transcription factor network—MYC—germ cell cancer	0.000308	0.00204	CbGpPWpGaD
L-Carnitine—Paraesthesia—Cisplatin—germ cell cancer	0.000306	0.00423	CcSEcCtD
L-Carnitine—Tachycardia—Etoposide—germ cell cancer	0.000305	0.00421	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000305	0.00202	CbGpPWpGaD
L-Carnitine—Dyspnoea—Cisplatin—germ cell cancer	0.000304	0.0042	CcSEcCtD
L-Carnitine—SLC22A5—spinal cord—germ cell cancer	0.000302	0.00163	CbGeAlD
L-Carnitine—Anorexia—Etoposide—germ cell cancer	0.000298	0.00411	CcSEcCtD
L-Carnitine—Decreased appetite—Cisplatin—germ cell cancer	0.000296	0.0041	CcSEcCtD
L-Carnitine—Diarrhoea—Dactinomycin—germ cell cancer	0.000295	0.00408	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000294	0.00407	CcSEcCtD
L-Carnitine—Vomiting—Bleomycin—germ cell cancer	0.000294	0.00407	CcSEcCtD
L-Carnitine—SLC22A4—brain—germ cell cancer	0.000294	0.00159	CbGeAlD
L-Carnitine—Depression—Methotrexate—germ cell cancer	0.000292	0.00404	CcSEcCtD
L-Carnitine—SLC22A5—female gonad—germ cell cancer	0.000292	0.00158	CbGeAlD
L-Carnitine—Hypotension—Etoposide—germ cell cancer	0.000292	0.00403	CcSEcCtD
L-Carnitine—Rash—Bleomycin—germ cell cancer	0.000292	0.00403	CcSEcCtD
L-Carnitine—Pain—Cisplatin—germ cell cancer	0.000292	0.00403	CcSEcCtD
L-Carnitine—Dermatitis—Bleomycin—germ cell cancer	0.000291	0.00403	CcSEcCtD
L-Carnitine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000291	0.00403	CcSEcCtD
L-Carnitine—Renal failure—Methotrexate—germ cell cancer	0.000288	0.00398	CcSEcCtD
L-Carnitine—SLC22A4—lymph node—germ cell cancer	0.000284	0.00153	CbGeAlD
L-Carnitine—Asthenia—Ifosfamide—germ cell cancer	0.000284	0.00392	CcSEcCtD
L-Carnitine—Paraesthesia—Etoposide—germ cell cancer	0.00028	0.00388	CcSEcCtD
L-Carnitine—Pruritus—Ifosfamide—germ cell cancer	0.00028	0.00387	CcSEcCtD
L-Carnitine—Dyspnoea—Etoposide—germ cell cancer	0.000278	0.00385	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000275	0.00182	CbGpPWpGaD
L-Carnitine—Nausea—Bleomycin—germ cell cancer	0.000275	0.0038	CcSEcCtD
L-Carnitine—Vomiting—Dactinomycin—germ cell cancer	0.000274	0.00379	CcSEcCtD
L-Carnitine—Rash—Dactinomycin—germ cell cancer	0.000272	0.00376	CcSEcCtD
L-Carnitine—Decreased appetite—Etoposide—germ cell cancer	0.000272	0.00375	CcSEcCtD
L-Carnitine—Diarrhoea—Ifosfamide—germ cell cancer	0.000271	0.00374	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00027	0.00373	CcSEcCtD
L-Carnitine—Body temperature increased—Cisplatin—germ cell cancer	0.000269	0.00372	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000269	0.00178	CbGpPWpGaD
L-Carnitine—Pain—Etoposide—germ cell cancer	0.000267	0.00369	CcSEcCtD
L-Carnitine—Constipation—Etoposide—germ cell cancer	0.000267	0.00369	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000265	0.00176	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SLC2A3—germ cell cancer	0.000265	0.00176	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000265	0.00176	CbGpPWpGaD
L-Carnitine—Haemoglobin—Methotrexate—germ cell cancer	0.000265	0.00366	CcSEcCtD
L-Carnitine—Haemorrhage—Methotrexate—germ cell cancer	0.000263	0.00364	CcSEcCtD
L-Carnitine—Dizziness—Ifosfamide—germ cell cancer	0.000261	0.00361	CcSEcCtD
L-Carnitine—Pharyngitis—Methotrexate—germ cell cancer	0.000261	0.00361	CcSEcCtD
L-Carnitine—CPT2—Metabolism—SLC22A3—germ cell cancer	0.000261	0.00173	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000261	0.00173	CbGpPWpGaD
L-Carnitine—SLC22A5—testis—germ cell cancer	0.000259	0.0014	CbGeAlD
L-Carnitine—SLC22A8—brain—germ cell cancer	0.000257	0.00139	CbGeAlD
L-Carnitine—Nausea—Dactinomycin—germ cell cancer	0.000256	0.00354	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—germ cell cancer	0.000256	0.0017	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000255	0.00353	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TP53—germ cell cancer	0.000255	0.00169	CbGpPWpGaD
L-Carnitine—Vomiting—Ifosfamide—germ cell cancer	0.000251	0.00347	CcSEcCtD
L-Carnitine—Hypersensitivity—Cisplatin—germ cell cancer	0.000251	0.00347	CcSEcCtD
L-Carnitine—Rash—Ifosfamide—germ cell cancer	0.000249	0.00345	CcSEcCtD
L-Carnitine—Dermatitis—Ifosfamide—germ cell cancer	0.000249	0.00344	CcSEcCtD
L-Carnitine—Abdominal pain—Etoposide—germ cell cancer	0.000247	0.00341	CcSEcCtD
L-Carnitine—Body temperature increased—Etoposide—germ cell cancer	0.000247	0.00341	CcSEcCtD
L-Carnitine—Eye disorder—Methotrexate—germ cell cancer	0.000246	0.0034	CcSEcCtD
L-Carnitine—Asthenia—Cisplatin—germ cell cancer	0.000245	0.00338	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000241	0.00159	CbGpPWpGaD
L-Carnitine—SLC22A5—cerebellum—germ cell cancer	0.000239	0.00129	CbGeAlD
L-Carnitine—Angiopathy—Methotrexate—germ cell cancer	0.000239	0.0033	CcSEcCtD
L-Carnitine—Nausea—Ifosfamide—germ cell cancer	0.000235	0.00325	CcSEcCtD
L-Carnitine—Diarrhoea—Cisplatin—germ cell cancer	0.000233	0.00322	CcSEcCtD
L-Carnitine—Hypersensitivity—Etoposide—germ cell cancer	0.00023	0.00318	CcSEcCtD
L-Carnitine—Dysgeusia—Methotrexate—germ cell cancer	0.000224	0.0031	CcSEcCtD
L-Carnitine—Asthenia—Etoposide—germ cell cancer	0.000224	0.0031	CcSEcCtD
L-Carnitine—Back pain—Methotrexate—germ cell cancer	0.000222	0.00306	CcSEcCtD
L-Carnitine—Pruritus—Etoposide—germ cell cancer	0.000221	0.00305	CcSEcCtD
L-Carnitine—Vomiting—Cisplatin—germ cell cancer	0.000217	0.003	CcSEcCtD
L-Carnitine—Rash—Cisplatin—germ cell cancer	0.000215	0.00297	CcSEcCtD
L-Carnitine—Dermatitis—Cisplatin—germ cell cancer	0.000215	0.00297	CcSEcCtD
L-Carnitine—Diarrhoea—Etoposide—germ cell cancer	0.000214	0.00295	CcSEcCtD
L-Carnitine—CPT2—Metabolism—CRABP1—germ cell cancer	0.000213	0.00141	CbGpPWpGaD
L-Carnitine—Anaemia—Methotrexate—germ cell cancer	0.000212	0.00293	CcSEcCtD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000209	0.00139	CbGpPWpGaD
L-Carnitine—Dizziness—Etoposide—germ cell cancer	0.000207	0.00285	CcSEcCtD
L-Carnitine—Vertigo—Methotrexate—germ cell cancer	0.000206	0.00285	CcSEcCtD
L-Carnitine—Nausea—Cisplatin—germ cell cancer	0.000202	0.0028	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—HRAS—germ cell cancer	0.000201	0.00133	CbGpPWpGaD
L-Carnitine—Cough—Methotrexate—germ cell cancer	0.0002	0.00276	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000199	0.00132	CbGpPWpGaD
L-Carnitine—Convulsion—Methotrexate—germ cell cancer	0.000199	0.00274	CcSEcCtD
L-Carnitine—Vomiting—Etoposide—germ cell cancer	0.000199	0.00274	CcSEcCtD
L-Carnitine—Rash—Etoposide—germ cell cancer	0.000197	0.00272	CcSEcCtD
L-Carnitine—Dermatitis—Etoposide—germ cell cancer	0.000197	0.00272	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000196	0.0013	CbGpPWpGaD
L-Carnitine—Headache—Etoposide—germ cell cancer	0.000196	0.0027	CcSEcCtD
L-Carnitine—Chest pain—Methotrexate—germ cell cancer	0.000195	0.0027	CcSEcCtD
L-Carnitine—Myalgia—Methotrexate—germ cell cancer	0.000195	0.0027	CcSEcCtD
L-Carnitine—SLC22A5—brain—germ cell cancer	0.000194	0.00105	CbGeAlD
L-Carnitine—SLC22A5—lymph node—germ cell cancer	0.000188	0.00101	CbGeAlD
L-Carnitine—Infection—Methotrexate—germ cell cancer	0.000186	0.00257	CcSEcCtD
L-Carnitine—Nausea—Etoposide—germ cell cancer	0.000186	0.00256	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—SLC2A3—germ cell cancer	0.000184	0.00122	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC22A3—germ cell cancer	0.000181	0.0012	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000181	0.0012	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.00018	0.00119	CbGpPWpGaD
L-Carnitine—Anorexia—Methotrexate—germ cell cancer	0.000178	0.00246	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000177	0.00118	CbGpPWpGaD
L-Carnitine—Hypotension—Methotrexate—germ cell cancer	0.000175	0.00242	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00017	0.00236	CcSEcCtD
L-Carnitine—Insomnia—Methotrexate—germ cell cancer	0.000169	0.00234	CcSEcCtD
L-Carnitine—Paraesthesia—Methotrexate—germ cell cancer	0.000168	0.00232	CcSEcCtD
L-Carnitine—Dyspnoea—Methotrexate—germ cell cancer	0.000167	0.0023	CcSEcCtD
L-Carnitine—Dyspepsia—Methotrexate—germ cell cancer	0.000165	0.00228	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000164	0.00108	CbGpPWpGaD
L-Carnitine—Decreased appetite—Methotrexate—germ cell cancer	0.000163	0.00225	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000162	0.00223	CcSEcCtD
L-Carnitine—Pain—Methotrexate—germ cell cancer	0.00016	0.00221	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000153	0.00211	CcSEcCtD
L-Carnitine—Abdominal pain—Methotrexate—germ cell cancer	0.000148	0.00204	CcSEcCtD
L-Carnitine—Body temperature increased—Methotrexate—germ cell cancer	0.000148	0.00204	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—CRABP1—germ cell cancer	0.000148	0.000978	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—germ cell cancer	0.000138	0.000915	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Methotrexate—germ cell cancer	0.000138	0.0019	CcSEcCtD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000137	0.000906	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000135	0.000893	CbGpPWpGaD
L-Carnitine—Asthenia—Methotrexate—germ cell cancer	0.000134	0.00185	CcSEcCtD
L-Carnitine—Pruritus—Methotrexate—germ cell cancer	0.000132	0.00183	CcSEcCtD
L-Carnitine—Diarrhoea—Methotrexate—germ cell cancer	0.000128	0.00177	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000124	0.000823	CbGpPWpGaD
L-Carnitine—Dizziness—Methotrexate—germ cell cancer	0.000124	0.00171	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000122	0.00081	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC2A3—germ cell cancer	0.000122	0.000807	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC22A3—germ cell cancer	0.00012	0.000795	CbGpPWpGaD
L-Carnitine—Vomiting—Methotrexate—germ cell cancer	0.000119	0.00164	CcSEcCtD
L-Carnitine—Rash—Methotrexate—germ cell cancer	0.000118	0.00163	CcSEcCtD
L-Carnitine—Dermatitis—Methotrexate—germ cell cancer	0.000118	0.00163	CcSEcCtD
L-Carnitine—Headache—Methotrexate—germ cell cancer	0.000117	0.00162	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000116	0.000765	CbGpPWpGaD
L-Carnitine—Nausea—Methotrexate—germ cell cancer	0.000111	0.00154	CcSEcCtD
L-Carnitine—XDH—Metabolism—CRABP1—germ cell cancer	9.78e-05	0.000648	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—AVP—germ cell cancer	9.19e-05	0.000609	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—AVP—germ cell cancer	8.31e-05	0.000551	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A3—germ cell cancer	6.41e-05	0.000425	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC22A3—germ cell cancer	6.31e-05	0.000418	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—AVP—germ cell cancer	6.31e-05	0.000418	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CRABP1—germ cell cancer	5.15e-05	0.000341	CbGpPWpGaD
